SCHEMBL7993467

SCHEMBL7993467

CCc1ccc2[nH]c(-c3ccc(C(=O)O)cc3)nc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 1/20 0.61
ALDH1A1 P00352 4/20 0.59
KDM4E B2RXH2 3/20 0.59
KMT2A Q03164 2/20 0.59
HPGD P15428 2/20 0.59
HDAC3 O15379 2/20 0.58
HDAC1 Q13547 2/20 0.58
HDAC8 Q9BY41 2/20 0.58
HDAC6 Q9UBN7 2/20 0.58
CHEK2 O96017 7/20 0.57
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
MMP8 P22894 1/20 0.55
MMP13 P45452 1/20 0.55
NR4A2 P43354 1/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
MEN1 O00255 1/20 0.52
POLB P06746 1/20 0.52
GAA P10253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7993472 0.90 MPL (0.71) MPLALDH1A1KDM4EKMT2AHPGD
SCHEMBL3567770 0.89 CHEK2 (0.66) MPLALDH1A1KDM4EKMT2AHPGD
SCHEMBL3569187 0.89 CHEK2 (0.66) MPLALDH1A1KDM4EKMT2AHPGD
SCHEMBL3925655 0.86 CHEK2 (0.68) MPLHDAC3HDAC1HDAC8HDAC6
SCHEMBL3917925 0.86 CHEK2 (0.68) MPLALDH1A1KDM4EKMT2AHPGD
SCHEMBL5189120 0.85 CHEK2 (0.69) MPLALDH1A1KDM4EKMT2AHPGD
SCHEMBL7602620 0.84 KDM4E (0.70) MPLALDH1A1KDM4EKMT2AHPGD
SCHEMBL11599478 0.84 KDM4E (0.70) MPLALDH1A1KDM4EKMT2AHPGD
SCHEMBL15788683 0.83 NPC1 (0.57) ALDH1A1KDM4EKMT2AHPGDHDAC3
SCHEMBL28930292 0.83 KDM4E (0.68) ALDH1A1KDM4EKMT2AHPGDHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010024833-A1 Methods for the solid phase synthesis of combinatorial libraries of benzimidazol, benzoxazoles, benzothiazoles, and derivatives thereof LABORDE EDGARDO (US) 2001-09-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010024833-A1 Methods for the solid phase synthesis of combinatorial libraries of benzimidazol, benzoxazoles, benzothiazoles, and derivatives thereof EIF2AK2, CDK15, CDK17 MPL 2107/4885ALDH1A1 3805/4885KDM4E 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.